Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2015 1
2016 2
2018 2
2019 1
2020 5
2021 5
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Third cranial nerve disorder"
Page 1
Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis.
Fritz D, van de Beek D, Brouwer MC. Fritz D, et al. BMC Neurol. 2016 Nov 15;16(1):220. doi: 10.1186/s12883-016-0741-x. BMC Neurol. 2016. PMID: 27846819 Free PMC article. Review.
Mean age at presentation was 43 years and neurological symptoms were the first clinical manifestation of sarcoidosis in 52%. The most commonly reported feature of neurosarcoidosis was cranial neuropathy in 55%, with the facial and optic nerve most commonly affected, …
Mean age at presentation was 43 years and neurological symptoms were the first clinical manifestation of sarcoidosis in 52%. The most common …
Sarcomas of the sellar region: a systematic review.
Guerrero-Pérez F, Vidal N, López-Vázquez M, Sánchez-Barrera R, Sánchez-Fernández JJ, Torres-Díaz A, Vilarrasa N, Villabona C. Guerrero-Pérez F, et al. Pituitary. 2021 Feb;24(1):117-129. doi: 10.1007/s11102-020-01073-9. Pituitary. 2021. PMID: 32785833 Review.
Median time between radiotherapy and sarcoma development was 10.5 (11) years. Main presentation symptoms were visual disorders (87.9%), headache (61.5%) and III cranial nerve palsy (24.1%). ...CONCLUSION: Sarcomas appear as mass effect symptoms in the middle …
Median time between radiotherapy and sarcoma development was 10.5 (11) years. Main presentation symptoms were visual disorders (87.9% …
Prevalence, clinical characteristics and outcomes of Guillain-Barré syndrome spectrum associated with COVID-19: A systematic review and meta-analysis.
Palaiodimou L, Stefanou MI, Katsanos AH, Fragkou PC, Papadopoulou M, Moschovos C, Michopoulos I, Kokotis P, Bakirtzis C, Naska A, Vassilakopoulos TI, Chroni E, Tsiodras S, Tsivgoulis G. Palaiodimou L, et al. Eur J Neurol. 2021 Oct;28(10):3517-3529. doi: 10.1111/ene.14860. Epub 2021 Apr 28. Eur J Neurol. 2021. PMID: 33837630 Free PMC article. Review.
BACKGROUND AND PURPOSE: Mounting evidence supports an association between Guillain-Barre syndrome spectrum (GBSs) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, GBSs in the setting of coronavirus disease 2019 (COVID-19) remains poorly …
BACKGROUND AND PURPOSE: Mounting evidence supports an association between Guillain-Barre syndrome spectrum (GBSs) and severe acute respirato …
Cranial Nerve Disorders Associated With Immune Checkpoint Inhibitors.
Vogrig A, Muñiz-Castrillo S, Joubert B, Picard G, Rogemond V, Skowron F, Egri M, Desestret V, Tilikete C, Psimaras D, Ducray F, Honnorat J. Vogrig A, et al. Neurology. 2021 Feb 9;96(6):e866-e875. doi: 10.1212/WNL.0000000000011340. Epub 2020 Dec 14. Neurology. 2021. PMID: 33318162
OBJECTIVE: To describe the spectrum, treatment, and outcome of cranial nerve disorders associated with immune checkpoint inhibitor (Cn-ICI). ...CONCLUSION: Cranial nerve disorders can complicate treatment with ICIs. Approximately one-t …
OBJECTIVE: To describe the spectrum, treatment, and outcome of cranial nerve disorders associated with immune checkpoin …
Malignant peripheral nerve sheath tumors of the eighth cranial nerve arising without prior irradiation.
Carlson ML, Jacob JT, Habermann EB, Glasgow AE, Raghunathan A, Link MJ. Carlson ML, et al. J Neurosurg. 2016 Nov;125(5):1120-1129. doi: 10.3171/2015.7.JNS151056. Epub 2016 Jan 8. J Neurosurg. 2016. PMID: 26745487 Review.
OBJECTIVE Malignant peripheral nerve sheath tumors (MPNSTs) of the eighth cranial nerve (CN) are exceedingly rare. ...Sixty-one percent of patients receiving treatment experienced recurrence, 22% of which were diagnosed with drop metastases to the spine. Ulti …
OBJECTIVE Malignant peripheral nerve sheath tumors (MPNSTs) of the eighth cranial nerve (CN) are exceedingly rare. ...S …
Treatment modalities of neurosensory deficit after lower third molar surgery: a systematic review.
Leung YY, Fung PP, Cheung LK. Leung YY, et al. J Oral Maxillofac Surg. 2012 Apr;70(4):768-78. doi: 10.1016/j.joms.2011.08.032. Epub 2011 Dec 16. J Oral Maxillofac Surg. 2012. PMID: 22177820 Review.
RESULTS: Ten articles entered the final review. Six treatment modalities of lingual nerve or inferior alveolar nerve deficit after lower third molar surgery were identified. ...There was insufficient information to determine the best timing of treatment of …
RESULTS: Ten articles entered the final review. Six treatment modalities of lingual nerve or inferior alveolar nerve deficit a …
Tolosa-Hunt Syndrome in Childhood and Adolescence: A Literature Review in the Last 10 Years.
Gama BP, Silva-Néto RP. Gama BP, et al. Neuropediatrics. 2021 Feb;52(1):1-5. doi: 10.1055/s-0040-1715632. Epub 2020 Sep 6. Neuropediatrics. 2021. PMID: 32892335
Magnetic resonance imaging showed inflammation in the cavernous sinus (100%), orbit (25%), and superior orbital fissure (8.3%), unilateral in all patients. The internal carotid artery (58.3%), third (66.7%), sixth (33.3%), and fourth (25%) cranial nerves were injure …
Magnetic resonance imaging showed inflammation in the cavernous sinus (100%), orbit (25%), and superior orbital fissure (8.3%), unilateral i …
Interventions for eye movement disorders due to acquired brain injury.
Rowe FJ, Hanna K, Evans JR, Noonan CP, Garcia-Finana M, Dodridge CS, Howard C, Jarvis KA, MacDiarmid SL, Maan T, North L, Rodgers H. Rowe FJ, et al. Cochrane Database Syst Rev. 2018 Mar 5;3(3):CD011290. doi: 10.1002/14651858.CD011290.pub2. Cochrane Database Syst Rev. 2018. PMID: 29505103 Free PMC article. Review.
BACKGROUND: Acquired brain injury can cause eye movement disorders which may include: strabismus, gaze deficits and nystagmus, causing visual symptoms of double, blurred or 'juddery' vision and reading difficulties. ...These trials included conditions of acquired nystagmus …
BACKGROUND: Acquired brain injury can cause eye movement disorders which may include: strabismus, gaze deficits and nystagmus, causin …
Coronectomy as a surgical approach to impacted mandibular third molars: a systematic review.
Martin A, Perinetti G, Costantinides F, Maglione M. Martin A, et al. Head Face Med. 2015 Apr 10;11:9. doi: 10.1186/s13005-015-0068-7. Head Face Med. 2015. PMID: 25890111 Free PMC article. Review.
The following variable were evaluated: inferior alveolar nerve injury, lingual nerve injury, postoperative adverse effects, pulp disease, root migration and rate of reoperation. ...Coronectomy was associated with a low incidence of complications in terms of i …
The following variable were evaluated: inferior alveolar nerve injury, lingual nerve injury, postoperative adverse effects, pu …
Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies.
Simard C, Vogrig A, Joubert B, Muñiz-Castrillo S, Picard G, Rogemond V, Ducray F, Berzero G, Psimaras D, Antoine JC, Desestret V, Honnorat J. Simard C, et al. Neurol Neuroimmunol Neuroinflamm. 2020 Mar 13;7(3):e699. doi: 10.1212/NXI.0000000000000699. Print 2020 May. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32170042 Free PMC article.
At the time the disease reached the plateau phase (median 12 weeks, range: 1-64 weeks; 28% >3 months), 24 (67%) showed an overt cerebellar syndrome, which was isolated in 3 patients, and was most frequently (21/24 cases) part of a multisystem neurologic disease. …
At the time the disease reached the plateau phase (median 12 weeks, range: 1-64 weeks; 28% >3 months), 24 (67%) showed an overt ce …
17 results